No Detail Found!

Comparative Study of the Protective E ects of Alpha-Lipoic Acid and Alpha-Tocopherol on Isoniazid-Induced Hepatitis in Mice

Author(s)
Ikram Ullah Khan Department of Pharmacology, Army Medical College,Rawalpindi,Pakistan
Shabana Ali Department of Pharmacology, NUST School of Health Sciences,Islamabad,Pakistan
Arooj Shahid Department of Pharmacology, Army Medical College,Rawalpindi,Pakistan
Muhammad Rafay Rasheed Department of Pharmacology, Army Medical College,Rawalpindi,Pakistan
Malik Sikandar Mehmood Department of Pharmacology, Army Medical College,Rawalpindi,Pakistan
Barkat Ullah Khan Department of Physiology, Army Medical College,Rawalpindi,Pakistan
Abstract
To assess the preventive role of alpha-tocopherol (vitamin E) and alpha-lipoic acid (ALA) in isoniazid-induced hepatitis. Study Design: Experimental study. Place and Duration of the Study: Department of Pharmacology, Army Medical College, National University of Medical Sciences, Rawalpindi, and National Institute of Health, Islamabad, Pakistan, from July 2020 to June 2022. Methodology: A total of 150 mice were taken and divided into ve groups, each containing 30 mice. Isoniazid was administered at a dose of 100 mg/kg orally for 28 days for the induction of hepatotoxicity. Alpha-lipoic acid and alpha-tocopherol were administered orally half an hour prior to the administration of isoniazid in a dose of 50 mg/kg and 100 mg/kg, respectively, alone and in combination for 28 days. Blood and liver samples were taken for biochemical and histopathological analysis, respectively. Statistical di erence between serum levels of liver enzymes on day 0 and day 28 was analysed using paired t-test. Results: Results showed protective e ects of ALA and alpha tocopherol against isoniazid-induced hepatotoxicity by reducing the serum levels of bilirubin and liver enzymes. Histopathology also indicated preservation of liver architecture against isoniazid-induced hepatitis by ALA and alpha tocopherol which was indicated by reduced necrosis, steatosis, and portal in ammation. Conclusion: The use of ALA and alpha-tocopherol may be helpful in preventing isoniazid-induced hepatotoxicity.
Publication Details
Page(s) 854-858
Published Journal: Journal of the College of Physicians and Surgeons Pakistan, Volume: 35, Issue: 07, Year: 2025

Request the full text from PASTIC

Keywords
Hepatitis, Isoniazid, Alpha Tocopherol, Alpha lipoic acid
References
. .treatment, update. World Health Organization; 2022, : .
Berhan A,Almaw A,Solomon Y,Legese B,Damtie S,Erkihun M .2023 .Tuberculosis treatment outcome and associated factors among tuberculosis patients linked to tuberculosis treatment clinics in Ethiopia, 2023: A multi-center retrospective study. Infect Drug Resist, 10 : 3367-78.
Amkongo M,Mitonga HK,Alfeus A,Shipingana LN,Keendjele T,Eelu H .2023 .Factors associated with the unsuccessful TB treatment outcomes in the northern regions of Namibia: A mixed methods study. BMC Infect Dis, 10 : 342.
Gill CM,Dolan L,Piggott LM,McLaughlin AM .2022 .New developments in tuberculosis diagnosis and treatment. Breathe (She ), 10(1) : 0149-2021.
Lim WS,Avery A,Kon OM,Dedicoat M .2023 .Anti-tuberculosis drug-induced liver injury. BMJ, 10 : .
Lewis JH,Korkmaz SY,Rizk CA,Copeland MJ CA .2024 .Diagnosis, prevention and risk-management of drug-induced liver injury due to medications used to treat mycobacterium tuberculosis. Expert Opin Drug Saf, 2399074(9) : 1093-107.
Zhuang X,Li L,Liu T,Zhang R,Yang P,Wang X .2022 .Mechanisms of isoniazid and rifampicin-induced liver injury and the e ects of natural medicinal ingredients: A review. Front Pharmacol, 103 : 1037814.
Khan S,Mandal RK,Elasbali AM,Dar SA,Jawed A,Wahid M .2019 .Pharmacogenetic association between NAT2 gene polymorphisms and isoniazid induced hepatotoxicity: Trial sequence meta-analysis as evidence. Biosci Rep, 10(1) : .
Poudel AN,Zhu S,Cooper N,Little P,Tarrant C,Hickman M .2023 .The economic burden of antibiotic resistance: A systematic review and meta-analysis. PLoS One, 0285170(5) : .
Nelson RE,Hat eld KM,Wolford H,Samore MH,Scott RD,Reddy SC .2021 .National estimates of healthcare costs associated with multidrug-resistant bacterial infections among hospitalized patients in the United States. Clin Infect Dis, 10(Suppl 1) : S17-26.
Fei M,Xie Q,Zou Y,He R,Zhang Y,Wang J .2016 .Alphalipoic acid protects mice against concanavalin A-induced hepatitis by modulating cytokine secretion and reducing reactive oxygen species generation. Int Immunopharmacol, 03 : 53-60.
Tanaka Y,Kaibori M,Miki H,Nakatake R,Tokuhara K,Nishizawa M .2014 .Alpha-lipoic acid exerts a liver-protective e ect in acute liver injury ratsJ. Surg Res2015, 08(2) : 675-83.
Wessam H,Ezzeddin S,Wessam H,Somaia A,Adel B,Naglaa A .2013 .Possible protection against isoniaizd induced hepatotoxicity by certain natural agents. Int J Pharm Res Bio-Sci, 2 : 345-61.
Amara IB,Soudani N,Troudi A,Bouaziz H,Boudawara T,Zeghal N. .2010 .Antioxidant e ect of vitamin E and selenium on hepatotoxicity induced by dimethoate in female adult rats. Ecotoxicol Environ Saf, 11(4) : 811-9.
Metushi IG,Nakagawa T,Uetrecht J .2012 .Direct oxidation and covalent binding of isoniazid to rodent liver and human hepatic microsomes: humans are more like mice than rats. Chem Res Toxicol, 10(11) : 2567-76.
Iluz-Freundlich D,Zhang M,Uhanova J,Minuk GY .2019 .The relative expression of hepatocellular and cholestatic liver enzymes in adult patients with liver disease. Ann Hepatol, 08(2) : 204-8.
Eminzade S,Uras F,Izzettin FV .2008 .Silymarin protects liver against toxic e ects of anti-tuberculosis drugs in experimental animals. Nutr, 10 : 1743.
Sharma S,Anand A,Verma N,Sharma V,Bhatia A,Patil AN . .Pharmacokinetic assessment of isoniazid and acetylisoniazid in carbon tetrachloride-induced liver injury model in wistar rats. J Pharm Bioallied, 10(3) : 23-45.
0

Citations

0

Downloads

88

Views